What You Need To Know About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) Investor Composition

What You Need To Know About La Jolla Pharmaceutical Company's (NASDAQ:LJPC) Investor Composition

The big shareholder groups in La Jolla Pharmaceutical Company (NASDAQ:LJPC) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. Companies that used to be publicly owned tend to have lower insider ownership.

La Jolla Pharmaceutical is a smaller company with a market capitalization of US$141m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about La Jolla Pharmaceutical.

See our latest analysis for La Jolla Pharmaceutical

ownership-breakdown
NasdaqCM:LJPC Ownership Breakdown June 10th 2021

What Does The Institutional Ownership Tell Us About La Jolla Pharmaceutical?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

La Jolla Pharmaceutical already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see La Jolla Pharmaceutical's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
NasdaqCM:LJPC Earnings and Revenue Growth June 10th 2021

It would appear that 45% of La Jolla Pharmaceutical shares are controlled by hedge funds. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Tang Capital Management, LLC is currently the largest shareholder, with 37% of shares outstanding. For context, the second largest shareholder holds about 8.5% of the shares outstanding, followed by an ownership of 5.5% by the third-largest shareholder.

A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 51% stake.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There is some analyst coverage of the stock, but it could still become more well known, with time.